Who is sponsoring NCT03893773?

NCT03893773 is sponsored by ZRMohamed.

What drugs are being tested in NCT03893773?

Interventions in NCT03893773: doppler ultrasonagraphy.

What condition does NCT03893773 study?

NCT03893773 studies Liver Transplant, Complications.

Is NCT03893773 still recruiting?

NCT03893773 is currently status unknown. Last updated 28 March 2019.

Last reviewed 2019-03-28 · How we verify

NCT03893773

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Doppler Ultrasonography in Assessment of Graft Hemodynamics After Living-Donor Liver Transplantation

Status unknown Last updated 28 March 2019

What this trial tests

trial testing doppler ultrasonagraphy in Liver Transplant, Complications in 50 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
30 April 2021

30 June 2021

Quick facts

Lead sponsor	ZRMohamed
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 April 2019
Primary completion	30 April 2021
Estimated completion	30 June 2021

Drugs / interventions tested

doppler ultrasonagraphy

Conditions studied

Liver Transplant, Complications — all drugs for Liver Transplant, Complications →

Sponsor

ZRMohamed

Who can join

Adults 18 to 70, any sex, with Liver Transplant, Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Graft ischemia after liver transplantation is associated with a high incidence of morbidity and mortality . The overall incidence of vascular complications in adults varies widely among transplant centers worldwide, but remains around 7% in various series of deceased donor liver transplantation (DDLT), and around 13% involving living donor liver transplantation (LDLT) Vascular complications include; hepatic artery thrombosis and stenosis, portal vein thrombosis and stenosis, caval and hepatic veins obstruction, arterial pseudo aneurysm. Biliary complications include; biliary leakage, stricture and obstruction .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Liver Transplant, Complications

Currently open trials in the same condition.

NCT06905054 — Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation · Phase 2 · recruiting
NCT06716541 — Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03893773 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ZRMohamed
Last refreshed: 28 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03893773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing